FHS Capital Seeds Hormonaly.ai to Scale Science-Backed Evidence Through Agentic AI Systems

FHS Capital announces seed investment in Hormonaly.ai, an agentic AI platform that scales science-backed evidence for personalized hormone health insights, not limited to women.